Treatment Options for Female Hair Loss
For female pattern hair loss (FPHL), topical 5% minoxidil foam applied once daily is the first-line treatment, which should be continued for at least 12 months to properly evaluate response, with maintenance therapy required indefinitely to sustain results. 1
Types of Female Hair Loss
There are two main types of hair loss affecting women:
Female Pattern Hair Loss (FPHL) - Most common type
- Progressive thinning of hair, especially in frontal, central, and parietal scalp
- May or may not have elevated androgen levels
- Characterized by follicular miniaturization
Alopecia Areata - Patchy hair loss
- Limited patches: Often resolves spontaneously
- Extensive/total/universal: More difficult to treat
Treatment Algorithm for FPHL
First-line Treatment:
- Topical 5% minoxidil foam once daily 1
- Continue for minimum 6 months before evaluating initial response
- Full evaluation at 12 months
- Must be continued indefinitely to maintain results
Second-line/Alternative Options:
Low-dose oral combination therapy 1
- Minoxidil 0.25 mg + spironolactone 25 mg once daily
- Particularly useful for women with signs of androgen excess
Platelet-rich plasma (PRP) therapy 1
- Initial phase: 3 sessions at 4-6 week intervals
- Maintenance: Sessions every 6 months
- Can be used alone or as adjunct to minoxidil
Low-level laser therapy 1
- Used 3 times weekly
- Minimal side effects
- Can increase total hair count
Spironolactone (25-200 mg daily) 1, 2
- Particularly effective when FPHL is associated with hyperandrogenism
- Acts as an androgen receptor antagonist
For Severe or Treatment-Resistant Cases:
Finasteride (1-2.5 mg daily) 1, 2
- May be effective in postmenopausal women
- Contraindicated in women of childbearing potential due to teratogenicity
- Warning: Pregnant women should not handle tablets
Hair transplantation 1
- For advanced FPHL resistant to medical treatments
- Requires well-preserved donor hair at the occipital region
Treatment for Alopecia Areata
Limited Patchy Hair Loss:
- Intralesional corticosteroids 3, 1
- Triamcinolone acetonide (5-10 mg/mL)
- Best for fewer than five patches of <3 cm diameter
Extensive Alopecia Areata:
- Contact immunotherapy 3, 1
- Diphenylcyclopropenone (DPCP)
- 50-60% of patients achieve worthwhile response
- Requires multiple hospital visits over several months
- Store solutions in the dark; patients should wear hat/wig for 24h after application
Monitoring Treatment Response
- 3-month mark: Early signs of improvement may be visible
- 6-month mark: Critical evaluation point; significant improvements should be noticeable
- 12-month mark: Comprehensive evaluation of treatment efficacy
- Evaluation methods: Standardized clinical photography, trichoscopy, hair counts, patient self-assessment 1
Important Considerations and Pitfalls
- Don't discontinue treatment prematurely - Results take 6-12 months to become apparent 1
- Rule out underlying conditions - Check thyroid function, iron stores, vitamin D levels 1
- Set realistic expectations - Treatments are better at preventing progression than stimulating regrowth 4
- Consider psychological impact - Hair loss can cause significant psychological distress in women 4, 5
- For cosmetic improvement - Wigs, hairpieces, and cosmetic camouflage can be helpful while awaiting treatment response 3, 1
Treatment Efficacy Evidence
- Minoxidil shows moderate to marked increase in hair regrowth compared to placebo, with an important increase in total hair count 6
- Low-level laser therapy shows improvement in total hair count compared to sham devices 6
- Finasteride 1mg has shown limited efficacy in premenopausal women but may be effective at higher doses (2.5mg) in postmenopausal women 2, 6
- All treatments need to be continued to maintain effect, as FPHL is a chronic progressive condition 4